Patent · US Active

Methods for isolating antibodies that bind sclerostin

US10562964B2 · kind B2 · utility

0Cited by
56References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 15, 2016
Grant dateFeb 18, 2020
Priority date
Expiry dateJun 4, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.